Anti-tumour necrosis factor agents and lipid profile: a class effect? [electronic resource]
Producer: 20080620Description: 895-6 p. digitalISSN:- 1468-2060
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Atherosclerosis -- metabolism
- Etanercept
- Female
- Humans
- Immunoglobulin G -- therapeutic use
- Infliximab
- Lipid Metabolism
- Lymphotoxin-alpha -- antagonists & inhibitors
- Male
- Middle Aged
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Rheumatic Diseases -- drug therapy
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Letter
There are no comments on this title.
Log in to your account to post a comment.